AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 36 filers reported holding AXSOME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,219,581 | -13.0% | 17,450 | -23.2% | 0.03% | -20.5% |
| Q1 2023 | $1,402,110 | -24.1% | 22,732 | -5.1% | 0.04% | -25.0% |
| Q4 2022 | $1,847,649 | +475.6% | 23,955 | +181.6% | 0.05% | +160.0% |
| Q4 2021 | $321,000 | +49.3% | 8,508 | +30.6% | 0.02% | +17.6% |
| Q3 2021 | $215,000 | -74.1% | 6,515 | -35.5% | 0.02% | -70.7% |
| Q2 2020 | $831,000 | -51.5% | 10,102 | -65.3% | 0.06% | -53.2% |
| Q1 2020 | $1,713,000 | +616.7% | 29,120 | +1160.1% | 0.12% | +785.7% |
| Q4 2019 | $239,000 | -30.7% | 2,311 | -86.5% | 0.01% | -53.3% |
| Q3 2019 | $345,000 | +169.5% | 17,069 | -25.5% | 0.03% | +114.3% |
| Q4 2017 | $128,000 | – | 22,911 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |